NEW YORK and TORONTO, March 28, 2024  – iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the fourth quarter and year-ended December 31, 2023. The Company’s Annual Report on Form 10-K (the “Annual Report”), which includes its audited consolidated financial statements for the year ended December 31, 2023 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, on the System for Electronic Document Analysis and Retrieval’s (SEDAR+) website at www.sedarplus.com, and on the Company’s website at www.iAnthus.com. The Company’s financial statements are reported in accordance with U.S. generally accepted accounting principles (“GAAP”). All currency is expressed in U.S. dollars.

2023 Financial Highlights

  • Revenue of $159.2 million, down 2.4% from the prior year.
  • Gross profit of $63.2 million, down 15.1% from the prior year.
  • Gross margin of 39.7%, reflecting a decrease of 5.9% from the prior year.
  • Net loss of $76.6 million, or a net loss of $0.01 per share, compared to a net loss of $449.4 million, or a net loss of $0.13 per share, in the prior year.
  • Adjusted EBITDA(1) of $8.3 million, down $0.1 million from the prior year. EBITDA and Adjusted EBITDA are non-GAAP measures. Reconciliation tables of EBITDA and Adjusted EBITDA as used in this press release to GAAP are included below.

Fourth Quarter 2023 Financial Highlights

  • Revenue of $40.9 million, a sequential decrease of 4.7% from Q3 2023 and an increase of 8.8% from the same quarter in the prior year.
  • Gross profit of $15.9 million, a sequential increase of 19.3% from Q3 2023 and a decrease of 1.1% from the same quarter in the prior year.
  • Gross margin of 38.9%, reflecting a sequential increase of 782bps when compared to Q3 2023 and a decrease of 389bps from the same quarter in the prior year.
  • Net loss of $18.7 million, or a net loss of less than $0.01 per share, compared to a net loss of $19.2 million, or a net loss of less than $0.01 per share in Q3 2023, and compared to a net loss of $43.7 million, or a net loss of $0.01 per share, in the same quarter in the prior year.
  • Adjusted EBITDA(1) of $2.8 million, a sequential increase from an Adjusted EBITDA of $0.8 million in Q3 2023, and a decrease from an Adjusted EBITDA of $3.5 million from the same quarter in the prior year. EBITDA and Adjusted EBITDA are non-GAAP measures. Reconciliation tables of EBITDA and Adjusted EBITDA as used in this press release to GAAP are included below.

Table 1: Financial Results

in thousands of US$, except per share amounts (audited)

FY2023

FY2022

Q4 2023

Q4 2022

Revenue

$

159,237

$

163,213

$

40,880

$

37,571

Gross profit

63,169

74,432

15,919

16,092

Gross margin

39.7 %

45.6 %

38.9 %

42.8 %

Net loss

(76,621)

(449,391)

(18,695)

(43,732)

Net loss per share

(0.01)

(0.13)

(0.00)

(0.01)

 

Table 2: Reconciliation of Net Loss to EBITDA and Adjusted EBITDA(1)

in thousands of US$

FY2023

FY2022

Q4 2023

Q4 2022

Net loss

$

(76,621)

$

(449,391)

$

(18,695)

$

(43,732)

Depreciation and amortization

27,170

31,390

6,773

6,602

Interest expense, net

15,741

18,572

4,105

3,514

Income tax expense (recovery)

16,699

10,691

4,148

(3,900)

EBITDA (Non-GAAP)(1)

$

(17,011)

$

(388,738)

$

(3,669)

$

(37,516)

Adjustments:

(Recoveries), write-downs and other charges, net

410

(846)

(57)

82

Inventory reserves and write-downs

946

–

24

–

Accretion expense

3,950

3,590

1,004

1,029

Share-based compensation(2)

4,535

30,431

980

2,938

Impairment loss

–

30,551

–

30,551

Losses from change in fair value of financial instruments

74

422

89

48

Loss on equity method investments

183

–

183

–

Non-recurring charges(3)

4,467

22,989

1,338

2,441

Loss on debt extinguishment(4)

1,288

316,577

–

–

Other income(5)

(973)

(1,279)

(164)

(562)

Debt obligation fees(6)

–

804

–

–

Interest and penalties related to income tax

10,463

4,372

3,070

4,497

Non-monetary gain from MPX NJ acquisition

–

(10,460)

–

–

Total Adjustments

$

25,343

$

397,151

$

6,467

$

41,024

Adjusted EBITDA (Non-GAAP)(1)

$

8,332

$

8,413

$

2,798

$

3,508

(1)

See “Non-GAAP Financial Information” below for more information regarding the Company’s use of non-GAAP financial measures.

(2)

2022 reflects significant share-based compensation expense related to the graded vesting from the restricted stock units and stock options
granted as a result of the consummation of the Company’s recapitalization transaction (the “Recapitalization Transaction”) as further
discussed in the Annual Report.

(3)

Includes one-time, non-recurring costs related to the Company’s Recapitalization Transaction, strategic review process, ongoing legal
disputes, severance and other non-recurring costs associated with having become a U.S. reporting company. These non-recurring costs
are offset by insurance proceeds received as reimbursement for certain legal costs incurred.

(4)

2023 reflects a one-time loss of $1.3 million on debt extinguishment related to the amendment of the $11.0 million senior secured bridge
notes issued by iAnthus New Jersey, LLC. 2022 reflects a one-time loss of $316.6 million on debt extinguishment related to the closing
of the Recapitalization Transaction.

(5)

2023 reflects $0.4 million of Employee Retention Tax Credits (“ERTCs”) and approximately $0.5 million related to gains from asset
disposals. 2022 reflects $0.2 million of ERTCs, accounts payable write-offs of $0.5 million and a one-time refund of community host
fees of $0.4 million.

(6)

2022 reflects accrued interest on the exit fee owed to the holders of the Company’s former 13.0% senior secured convertible debentures
(the “Secured Notes”). As of the closing of the Recapitalization Transaction on June 24, 2022, the Secured Notes and the associated exit
fee were forgiven in part, and therefore, the Company will no longer incur debt obligation fees related to the Secured Notes.

Non-GAAP Financial Information

This press release includes certain non-GAAP financial measures as defined by the SEC and the Canadian Securities Administrators. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in the tables above. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.

In evaluating our business, we consider and use EBITDA and Adjusted EBITDA as supplemental measures of operating performance. We define EBITDA as earnings before interest, taxes, depreciation and amortization. We define Adjusted EBITDA as EBITDA before share-based compensation, accretion expense, write-downs and impairments, gains and losses from changes in fair values of financial instruments, income or losses from equity-accounted investments, the effect of changes in accounting policy, non-recurring costs related to the Company’s Recapitalization Transaction, litigation costs related to ongoing legal proceedings, and other income. We present EBITDA because we believe it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance of other similarly situated companies in our industry, and we present Adjusted EBITDA because it removes non-recurring, irregular and one-time items that we believe may distort the comparability of EBITDA from period-to-period and with other industry participants.

EBITDA and Adjusted EBITDA are not standardized financial measures defined under GAAP, and are not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. EBITDA and Adjusted EBITDA have limitations as an analytical tool, and when assessing the Company’s operating performance, investors should not consider EBITDA or Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP. Among other things, EBITDA and Adjusted EBITDA do not reflect the Company’s actual cash expenditures. Other companies may calculate similar measures differently than us, limiting their usefulness as comparative tools. We compensate for these limitations by relying on GAAP results and using EBITDA and Adjusted EBITDA only as supplemental information.

About iAnthus

iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States. For more information, visit www.iAnthus.com.

Post Views: 418